Welsis Corp.
Welsis Corp. does not have significant operations. It intends to enter the cryptocurrency and blockchain industry by launching TokenTraders.net, a crypto-exchange site. The company was incorporated in 2021 and is based in Philadelphia, Pennsylvania.
Welsis Corp. (WLSS) - Net Assets
Latest net assets as of September 2025: $-150.33K USD
Based on the latest financial reports, Welsis Corp. (WLSS) has net assets worth $-150.33K USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($2.17K) and total liabilities ($152.50K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-150.33K |
| % of Total Assets | -6930.89% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Welsis Corp. - Net Assets Trend (2022–2025)
This chart illustrates how Welsis Corp.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Welsis Corp. (2022–2025)
The table below shows the annual net assets of Welsis Corp. from 2022 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-09-30 | $-150.33K | -67.70% |
| 2024-09-30 | $-89.64K | +24.02% |
| 2023-09-30 | $-117.97K | -53.40% |
| 2022-09-30 | $-76.91K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Welsis Corp.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 12644100.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (September 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $75.80K | % |
| Total Equity | $-150.33K | 100.00% |
Welsis Corp. Competitors by Market Cap
The table below lists competitors of Welsis Corp. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
MANTLE MINERALS
F:MXB0
|
$2.29 Million |
|
UV GERMI S.A. EO -15
F:1NY
|
$2.29 Million |
|
Natus Medical Incorporated
F:NM4
|
$2.29 Million |
|
Adgar Investments and Development Ltd
TA:ADGR
|
$2.29 Million |
|
Marley Spoon Group SE
XETRA:MS1
|
$2.29 Million |
|
POSCO
KQ:005490
|
$2.29 Million |
|
Susglobal Energy Corp
OTCQB:SNRG
|
$2.28 Million |
|
Clal Industries and Beverages Ltd
TA:CLBV
|
$2.28 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Welsis Corp.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from -89,641 to -150,331, a change of -60,690.
- Net loss of 60,690 reduced equity.
- Other factors decreased equity by 0.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-60.69K | -40.37% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Welsis Corp.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2022-09-30 | $-0.03 | $3.04 | x |
| 2023-09-30 | $-0.04 | $3.04 | x |
| 2024-09-30 | $-0.03 | $3.04 | x |
| 2025-09-30 | $-0.05 | $3.04 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Welsis Corp. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is below the historical average (0.00%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2022 | 0.00% | 0.00% | 0.00x | 0.00x | $-35.09K |
| 2023 | 0.00% | -132.91% | 0.93x | 0.00x | $-29.27K |
| 2024 | 0.00% | -1234.15% | 0.00x | 0.00x | $-15.72K |
| 2025 | 0.00% | 0.00% | 0.00x | 0.00x | $-45.66K |
Industry Comparison
This section compares Welsis Corp.'s net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $79,108,599
- Average return on equity (ROE) among peers: -247.59%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Welsis Corp. (WLSS) | $-150.33K | 0.00% | N/A | $2.29 Million |
| Accolade, Inc. (ACCD) | $473.79 Million | -97.02% | 0.91x | $448.32 Million |
| Achiko AG (ACHKF) | $-4.58 Million | 0.00% | 0.00x | $314.42K |
| Ascom Holding AG (ACMLF) | $78.70 Million | 22.11% | 1.51x | $152.13 Million |
| Accelera Innovations Inc (ACNV) | $-462.52K | 0.00% | 0.00x | $5.72K |
| Aclarion Inc (ACON) | $-7.08 Million | 0.00% | 0.00x | $1.89 Million |
| Alternate Health Corp (AHGIF) | $1.07 Million | -2231.82% | 7.94x | $6.50K |
| AI/ML Innovations Inc (AIMLF) | $2.09 Million | -130.52% | 0.72x | $6.84 Million |
| NetraMark Holdings Inc. (AINMF) | $-198.56K | 0.00% | 0.00x | $70.13 Million |
| AMJ Global Technology (AMJT) | $-21.78K | 0.00% | 0.00x | $10.99 Million |
| American Well Corp (AMWL) | $247.79 Million | -38.62% | 0.31x | $78.62 Million |